EnlivenHealth Celebrates American Pharmacists Month » Learn More

EnlivenHealth Weekly Recap | April 12th, 2025

Here are the top stories from the last week:

Industry Updates

Take a Tour through Thrifty White Pharmacy’s Central Fill Facility
Learn more about Thrifty White Pharmacy’s central fill facility in Fargo, N.D., which uses technology to streamline pharmacy operations. By centralizing the dispensing workload, local pharmacy teams can focus more on clinical services and patient engagement. Watch video »

Retail Pharmacy Must Mine the Gaps
The article discusses how retail pharmacies are expanding their roles in healthcare by adopting new care models that emphasize value-based, patient-centered approaches. It highlights the collaboration between pharmacies and primary care providers, the integration of technology, and the potential for legislative changes to expand pharmacists’ roles. Read article »

Study Reveals Impact on Utilization and Cost of Point-of-Sale Diagnosis Verification of GLP-1s
Automated diagnosis verification offers a promising alternative for managing the use of GLP-1 medications. Read article »

Pharmacists Face Key Knowledge Barriers to Ensuring Effective Pneumococcal Vaccination
In a survey among community pharmacists in South Carolina, many pharmacists were unable to correctly identify proper pneumococcal vaccination guideline, raising concerns. Read article »

Hold the Joint, the Federal Marijuana Movement Just Hit the Brakes
Efforts to legalize marijuana across the country are stalling as many other issues on the new administration’s plate are taking priority. Read article »

PCSC expands GDP Program with Addition of 4 Accredited Companies
The Good Distribution Practices Accreditation Program aims to support pharmaceutical supply chain stakeholders, especially vendor service providers, in demonstrating compliance with globally recognized GDP operational and training standards. Read article »

NCPA Urges SCOTUS to Reject Radical Change to Legal Procedure That Could Limit Class Action Cases
Cases against PBMs and big insurers could be bogged by procedural hurdles if SCOTUS sides with petitioner, NCPA says. Read article »

Biosimilars Council’s Craig Burton Testifies Before Congress on Biosimilars Crisis
Regulatory obstacles and anticompetitive abuses threaten patient care; American healthcare system on track to lose $189 billion in patient savings. Read article »

Drug & Technology Updates

FDA Clears Dexcom G7 15 Day for Diabetic Patients 18 and Older
“The approval of Dexcom G7 15 Day marks another major innovation for Dexcom,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “By listening to the needs of our users, we’re proud to offer the longest lasting wearable and most accurate CGM, giving people the knowledge to better control their diabetes.”  Read article »

Camber Launches Mycophenolate Mofetil Capsules
Mycophenolate mofetil capsules, USP 250 mg — an immunosuppressant drug used in the treatment of several autoimmune diseases — are now available in 100 and 500 count bottles. Read article »

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI Injection
EPYSQLI® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized myasthenia gravis in adults who are anti-acetylcholine receptor antibody positive. Read article »

X

Amplicare is now part of EnlivenHealth®

X

FDSRX is now part of EnlivenHealth®